This paper is only available as a PDF. To read, Please Download here.
- A New Zealand randomized comparative study of three lUDs (Nova T®, MLCu375, MLAgCu250): 1–, 2– and 3–year results.Adv Contracept. 1992; 8: 153-159
- A randomized multicentre trial of the Multiload 375 and TCu380A lUDs in parous women: three-year results.Contraception. 1994; 49: 543-549
- Effective contraception with the levonorgestrel-releasing intrauterine device: 12–month report of a European multicenter study.Contraception. 1987; 36: 161-179
- Randic L An evaluation of the T Cu380 Ag and the Multiload Cu375.Fertil Steril. 1985; 43: 214-217
- Task Force on IUD. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380 Ag, CuT 220C and CuT 220B).Contraception. 1989; 39: 37-52
- Five years’ experience of intrauterine contraception with the Nova-T® and the Copper-T 200.Am J Obstet Gynecol. 1983; 147: 885-892
- A comparative clinical trial of the TCu 380 Ag, Lippes Loop D, and Multiload Cu 375 lUDs in Indonesia.Contraception. 1991; 44: 141-154
- Long-acting, more effective Copper T lUDs: a summary of US experience, 1970–75.Stud Fam Plann. 1979; 10: 263-281
- Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380 Ag and levonorgestrel 20μg/day devices.Contraception. 1987; 35: 245-255
- The TCu 380 A IUD and the frameless IUD “the Flexigard:” interim three-year data from an international multicentre trial.Contraception. 1995; 52: 77-83
- Mechanism of action, safety and efficacy of intrauterine devices. WHO, Geneva1987 (Technical Report Series 753)
- IUD use and endometrial bleedings.in: Bardin CW Mishell Jr, DR Proceedings from the Fourth International Conference on lUDs. Butterworth-Heinemann, Boston, Mass1994: 210-218
- The influence of the Gyne-T 380S® IUD on menstrual blood loss and iron status.Contraception. 1995; 52: 175-179
- Association between intrauterine devices and pelvic inflammatory disease.Obstet Gynecol. 1981; 57: 269-276
- Type of intrauterine device and the risk of pelvic inflammatory disease.Obstet Gynecol. 1983; 62: 1-6
- The intrauterine device and pelvic inflammatory disease: the Women’s Health Study reanalyzed.J Clin Epidemiol. 1991; 44: 109-122
- What we have learned from recent IUD studies: a researcher’s perspective.Contraception. 1993; 48: 81-108
- Intrauterine devices and pelvic inflammatory disease: an international perspective.Lancet. 1992; 339: 785-788
- Churchill Livingstone, London1993: 323-324 (Second Edition) Contraception.
- 1995: 22 (Volume XXII, Series B, Number 6) The Johns Hopkins School of Public Health, Baltimore.
- Pregnancy outcome associated with the use of lUDs.Br J Fam Plann. 1989; 15: 7-10
- Pregnancy outcome with removal of intrauterine device.Obstet Gynecol. 1973; 41: 894-896
- Management and outcome of pregnancies associated with the Copper T intrauterine devices.Am J Obstet Gynecol. 1976; 126: 869-879
- Long-term contraception with the Levonorgestrel 20 mcg/day (Lng 20) and the Copper T 380Ag intrauterine devices: a five-year randomized study.Contraception. 1990; 42: 361-378
- 1995: 10 (Volume XXII, Series B, Number 6) The Johns Hopkins School of Public Health, Baltimore.
- Reduction by mefenamic acid of increased menstrual blood loss associated with intrauterine contraception.Br J Obstet Gynaecol. 1978; 85: 53-62
© 1998 Published by Elsevier Inc.